top of page
Home
All News
Pharma
APAC
Brazil
Canada Pharma
China Pharma
Europe Pharma
India Pharma
Japan Pharma
North America
Saudi Arabia
US FDA Approvals
Therapy News
Immunology
Neurology
Oncology
Kidney Diseases
Cardiovascular
Infections_Vaccines
Metabolic Diseases
Women Health
Healthcare News
US Healthcare News
US Payer News
Europe Healthcare News
Germany Healthcare
Italy
United Kingdom Healthcare
APAC - Healthcare News
Brazil Healthcare
Healthcare Policies
Conferences
About
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
US_PayerNews
Radioligand therapy
NICE recommendations
Germany Healthcare Pharma News
HAS Assessment Outcomes
Neurology
Immunology
Blood Disorders
Oncology
Kidney Diseases
Cardiovascular Diseases
Infectious_Vaccines
Search
Saudi SFDA Launches NADR Program to Accelerate Rare Disease Drug Access
Badari Andukuri
Aug 15
Saudi Arabia Grants World’s First Approval for Iberdomide in Multiple Myeloma | iPharmaCenter
Badari Andukuri
Aug 14
SFDA Grants Promising Drug Status to Novo Nordisk’s Frehemgo for Hemophilia A | iPharmaCenter
Badari Andukuri
May 28
SFDA approved the registration of Anktiva for selected bladder and lung cancer indications | iPharmaCenter
Badari Andukuri
Jan 24
Saudi Arabia | Healthcare System | Drug approvals and pricing | iPharmaCenter
Badari Andukuri
Dec 27, 2022
bottom of page
